Tag: cLOD

Clinical Limit of Detection May Represent Viable cfDNA Metric For Detection of Multiple Cancers

Data were taken from a prospective, multi-center, observational study (NCT02889978), which evaluated cell-free DNA multi-omics in prototype cfDNA-based multi-cancer early detection tests. In the study, researchers collected plasma and matched white blood cells before sequencing them from CCGA study participants (n = 2,800). Tumor biopsies were also sequenced when available….

Continue Reading Clinical Limit of Detection May Represent Viable cfDNA Metric For Detection of Multiple Cancers

cLOD May Provide More Accurate Evaluation of Cell-Free DNA in Multi-Cancer Early Detection

Clinical limit of detection may be a reasonable metric for evaluating cell-free DNA for multi-cancer early detection. Clinical limit of detection (cLOD) may be a reasonable metric for evaluating cell-free DNA (cfDNA) for multi-cancer early detection, according to recent data from the Circulating Cell-Free Genome Atlas (CCGA) study (NCT02889978). In…

Continue Reading cLOD May Provide More Accurate Evaluation of Cell-Free DNA in Multi-Cancer Early Detection